The Human Microbiome: Its Impact on Health and Disease

The trillions of microorganisms living in and on the human body influence health in ways that extend far beyond digestion. Collectively called the microbiome, these bacteria, viruses, fungi, and archaea shape immune development, metabolic function, mental health, drug metabolism, and susceptibility to diseases ranging from inflammatory bowel disease to cardiovascular illness. Research over the past two decades has reframed the microbiome from a passive collection of hitchhikers into an active organ-like system whose composition can tip the balance between health and disease.

How the Microbiome Assembles in Early Life

Your microbiome begins forming at birth, and those first exposures matter for months or even years afterward. A study tracking 34 mother-infant pairs found that whether a baby was born at home or in a hospital had a visible effect on gut bacteria composition at six months of age, well after the differences linked to vaginal versus cesarean delivery had faded. Home-born infants acquired most of their mother’s microbial strains earlier, while cesarean-delivered infants did not pick up many of those strains until after six months. The researchers attributed part of the longer-term effect to breastfeeding duration, which tended to be longer among the home-birth group.¹

The introduction of solid foods triggers the biggest early shift in gut ecology, with dramatic increases in microbial diversity and a broad restructuring of which species dominate. Weaning from breast milk, by contrast, has a subtler overall effect but is specifically associated with declines in several Bifidobacterium species, underscoring the sustained role human milk plays in feeding particular beneficial bacteria. Cesarean delivery temporarily reduces the abundance of Bacteroides in the infant gut, but breastfeeding appears to compensate by supporting Bifidobacterium populations regardless of delivery mode.²

The Microbiome and the Immune System

The gut microbiome acts as a kind of training ground for the immune system, particularly in the first years of life. The composition of gut bacteria shapes how immune cells develop and determines the strength and tone of immune responses. In return, those immune signals feed back to the intestinal lining, reinforcing or weakening the barrier that separates gut contents from the bloodstream.³ When this barrier weakens, bacterial fragments and inflammatory molecules can leak into circulation, triggering immune activation in distant organs. That crosstalk between microbes and immunity runs throughout the body’s relationship with its resident organisms, surfacing in nearly every disease area researchers have examined.

Metabolic Health and the Chemicals Microbes Produce

One of the clearest ways gut bacteria affect health is through the molecules they manufacture. When microbes ferment dietary fiber, they produce short-chain fatty acids, primarily acetate, propionate, and butyrate. These compounds have anti-inflammatory, immune-regulating, and metabolic effects throughout the body.⁴ They also directly influence appetite regulation, energy expenditure, and blood sugar control. Boosting their production through diet has been proposed as a strategy for preventing obesity and type 2 diabetes.⁵

Beyond these beneficial metabolites, the bacterial makeup of the gut correlates with metabolic status. People with obesity tend to carry different proportions of major bacterial groups compared with lean individuals, with increases in Firmicutes and Actinobacteria and decreases in Bacteroidetes. These shifts are not just cosmetic differences in the microbial census; the altered community appears to extract more calories from food and promote fat storage.⁶ Whether these bacterial changes cause obesity or result from it remains an area of active investigation, but the association is robust and reproducible across many studies.

The Gut-Brain Axis

The gut and brain communicate constantly, and the microbiome is a major intermediary in that conversation. The vagus nerve, the longest cranial nerve in the body, serves as a physical highway for signals traveling in both directions between the intestinal environment and the central nervous system.⁷ But the vagus nerve is not the only channel. Gut bacteria also produce neurotransmitters like serotonin and gamma-aminobutyric acid, generate inflammatory signals that reach the brain through the bloodstream, and influence the stress hormone cortisol. Disruptions in the gut microbial community have been linked not only to intestinal diseases but also to mood disorders and neurodegenerative conditions.⁸

This connection is one of the more exciting and overhyped areas of microbiome science simultaneously. Animal studies are dramatic: transplanting gut bacteria from anxious mice into calm ones can change behavior. Human evidence is growing but still limited, and claims that a particular probiotic will fix depression should be met with healthy skepticism. The mechanisms are real; the therapeutic applications are still catching up.

Inflammatory Bowel Disease

Crohn’s disease and ulcerative colitis, the two major forms of inflammatory bowel disease, are among the conditions most clearly associated with gut microbial disruption.⁹ People with these diseases consistently show reduced microbial diversity along with an enrichment of less common and often inflammatory bacterial groups.¹⁰ Specifically, pro-inflammatory genera like Fusobacterium and Morganella tend to be enriched, while bacteria that produce beneficial short-chain fatty acids, such as Ruminococcus and Agathobacter, are markedly depleted.¹¹

The frustrating open question is causality. The microbial shifts in inflammatory bowel disease are consistent and well-documented, but whether they drive the disease or are a consequence of intestinal inflammation reshaping the microbial neighborhood remains unclear. The answer is probably both, in a feedback loop that is difficult to untangle.

Cardiovascular Disease and TMAO

The microbiome’s influence on heart health works through a somewhat unexpected route. When gut bacteria digest certain nutrients found in red meat, eggs, and dairy, they produce a compound called trimethylamine, which the liver then converts to trimethylamine N-oxide, or TMAO. Elevated blood levels of TMAO are associated with a higher risk of cardiovascular events and appear to promote atherosclerosis by influencing traditional risk factors like cholesterol metabolism and arterial inflammation.¹² TMAO is not the only microbial metabolite linked to heart disease; phenylacetylglutamine, another gut-bacteria-dependent compound, has more recently been associated with cardiovascular risk in large clinical studies.¹³

The practical implication here is nuanced. Eliminating red meat and eggs is not necessarily the takeaway. How much TMAO your body produces from a given meal depends on which microbes live in your gut, which in turn reflects your long-term diet. Someone whose microbiome has been shaped by years of high-fiber, plant-rich eating may produce far less TMAO from the same steak than someone with a microbial community primed by a heavily processed diet.

Microbiomes Beyond the Gut

Although the gut gets the most attention, every external and mucosal surface of the body hosts its own microbial community, and disruptions in these communities are tied to distinct diseases.

On the skin, dysbiosis is closely linked to common inflammatory conditions. The skin of people with atopic dermatitis (eczema) shows reduced microbial diversity and is dominated by the pathogen Staphylococcus aureus. Other bacterial species, including certain Staphylococcal and Roseomonas strains, can inhibit S. aureus growth and are being explored as topical probiotics for eczema.¹⁴ Similar microbial imbalances have been described in acne and psoriasis.¹⁵

In the mouth, chronic periodontitis has emerged as more than a dental problem. It can develop into a systemic condition marked by persistent inflammation, immune disruption, and dysbiosis that extends beyond the oral cavity into the gut and elsewhere, potentially causing or worsening other health issues.¹⁶

The vaginal microbiome is a particularly clear example of a healthy community being defined by low diversity. A healthy vaginal environment is dominated by Lactobacillus species, which produce antimicrobial compounds that suppress harmful bacteria.¹⁷ When Lactobacillus declines and anaerobic bacteria overgrow, the result is bacterial vaginosis, the most common gynecological condition among women of reproductive age. The consequences extend beyond discomfort to include increased susceptibility to sexually transmitted infections, pelvic inflammatory disease, miscarriages, preterm delivery, and infertility.¹⁸

How Gut Microbes Change the Way Drugs Work

Your microbiome can alter the effectiveness and safety of medications you take. Gut bacteria carry a suite of enzymes that modify drug molecules through reactions the human body does not perform on its own. Some of these transformations are helpful: certain prodrugs, which are inactive when swallowed, depend on bacterial enzymes to release their active ingredient.¹⁹ In other cases, microbial metabolism is harmful. In mouse experiments with the antiviral drug brivudine, about 70% of the drug’s liver toxicity was traced to gut bacteria rather than to the host’s own metabolism.²⁰

This field, sometimes called pharmacomicrobiomics, is still young. The practical upshot is that two people taking the same medication at the same dose can have very different outcomes partly because their gut bacteria process the drug differently. It is one more reason identical prescriptions do not always produce identical results.

Cancer Immunotherapy and the Microbiome

One of the most striking microbiome findings in recent years involves cancer treatment. Patients who respond to immune checkpoint inhibitors, a class of drugs that unleash the immune system against tumors, consistently harbor a different gut microbial community from those who do not respond. In mouse models, transplanting fecal bacteria from human responders promotes a response to immunotherapy, while bacteria from nonresponders fail to do so. Perhaps most strikingly, fecal transplants from patients who achieved a complete response to these drugs have been able to overcome drug resistance in patients whose tumors had stopped responding to treatment.²¹

Early work characterizing which specific bacteria differ between responders and nonresponders has identified trends. In one study of cancer patients on immunotherapy, nonresponders were enriched in bacteria from the genus Enterocloster along with Hungatella hathewayi and Cutibacterium acnes, while responders carried more Bacteroides species.²² The clinical translation is still underway, but the idea that your gut bacteria might determine whether an expensive cancer drug works is a remarkable reframing of how we think about treatment.

Fecal Microbiota Transplantation

If the microbiome can be disrupted in disease, can it be deliberately restored? The most successful example so far is fecal microbiota transplantation for recurrent Clostridioides difficile infection, a debilitating gut infection that often returns after antibiotic treatment. Transplanting stool from a healthy donor into the patient’s colon restores a functional microbial community and achieves cure rates of around 90%. The mechanism involves both direct competition against C. difficile and restoration of bile acid and short-chain fatty acid metabolism, along with immune recalibration mediated by regulatory T cells.²³²⁴

Fecal transplantation for C. difficile is the proof of concept. Extending the approach to obesity, inflammatory bowel disease, and other conditions has produced far more mixed results. The microbiome is not a single knob you can turn; it is a complex ecosystem, and simply adding bacteria does not guarantee they will take root or produce the desired effects.

What Antibiotics Do to the Microbiome

Antibiotics are the most common cause of sudden microbial disruption, and the aftermath is more complicated than “take a probiotic and you’ll be fine.” A course of antibiotics triggers a rapid drop in species diversity and shifts in which bacterial families dominate the gut. Antibiotic resistance genes also spike, linked in part to the expansion of Enterobacteriaceae during treatment.²⁵ Recovery timelines vary. After a short course of amoxicillin-clavulanic acid, both the microbiota and the resistance gene profile returned to baseline roughly one week after stopping the drug. But for broader-spectrum or longer antibiotic regimens, recovery looks different. One study found that while overall species richness recovered within about two months after common outpatient antibiotics, the taxonomy, metabolic output, and antibiotic resistance burden remained altered. The antibiotic azithromycin in particular delayed recovery of species richness and left a greater compositional gap compared with pre-treatment.²⁶

Long-term consequences of repeated antibiotic exposure include increased risk of antibiotic resistance, obesity, allergies, and asthma, effects that are especially concerning when exposure occurs prenatally or in early childhood.²⁷ None of this means you should refuse antibiotics when you need them. It does mean the old habit of prescribing antibiotics for mild, likely viral infections carries a hidden cost.

Diet as a Microbiome Lever

Dietary fiber is the primary fuel for the bacteria that produce beneficial short-chain fatty acids, and eating more of it is the most consistently supported dietary strategy for shaping a healthier microbial community.²⁸ Fermented foods add another dimension. Consuming yogurt, kimchi, kefir, and similar products is associated with detectable differences in the gut microbiome, including enrichment of conjugated linoleic acid, a potentially health-promoting molecule. These effects are modest but persistent.²⁹ Fermented foods can affect the gut microbiome in both the short and long term and are increasingly considered an important element of the diet.³⁰

The commercial probiotic market has raced far ahead of the science. Most over-the-counter probiotic supplements contain a handful of generic strains that may or may not colonize your gut, and many products make health claims that have not been rigorously tested. Eating a diverse, fiber-rich diet with some fermented foods is a more evidence-supported strategy than buying capsules of freeze-dried bacteria.

The Forgotten Members of the Microbiome

Bacteria dominate the microbiome conversation, but the ecosystem also includes viruses (mostly bacteriophages that infect bacteria), fungi, and archaea. These non-bacterial members have their own effects on health. In the gut, the viral, fungal, and archaeal communities are all altered in obesity and appear to influence host body composition and physiology in ways distinct from bacteria.³¹ The concept of the “multibiome,” encompassing bacteria, viruses, fungi, and even parasitic worms as parts of a single intestinal ecosystem, reflects a growing recognition that focusing on bacteria alone gives an incomplete picture, especially in immune-mediated diseases like inflammatory bowel disease and multiple sclerosis.³²

What Industrialization Has Done to Our Microbes

Some of the most thought-provoking microbiome research comes from comparisons between industrialized populations and traditional societies. The Hadza hunter-gatherers of Tanzania harbor a level of gut microbial diversity that almost certainly represents the ancestral state for humans. That diversity has declined in industrialized populations, and with it, microbial stability, both of which carry major implications for metabolic, immunologic, and gastrointestinal health.³³

Ultra-deep sequencing of Hadza gut samples has identified 124 species that are vanishing in industrialized populations, many of which appear to perform functions no longer represented in Western guts.³⁴ The Hadza microbiome also cycles seasonally in sync with shifting food sources, and the bacterial groups that fluctuate the most with the seasons are the same ones that differentiate industrialized from traditional populations across studies of 18 populations in 16 countries. In other words, some of the microbes most sensitive to environmental change are precisely the ones modern lifestyles have selected against.³⁵

Whether we can or should try to recover those lost microbes is an open question. The broader lesson is clear: the sanitized, low-fiber, antibiotic-heavy lifestyle of industrialized societies has fundamentally reshaped the microbial communities we co-evolved with, and the health consequences are still coming into focus.

Your Microbiome as a Fingerprint

The microbiome is personal enough to serve as a form of identification. Skin microbial communities vary more between different people than they change over time on the same person, making them a potential forensic tool.³⁶ Researchers have demonstrated that bacteria left on objects like computer keyboards and mice can be recovered and matched to the person who touched them, even after the objects have sat untouched for two weeks.³⁷

Standard methods for profiling bacteria have limited resolution for distinguishing between individuals. But newer approaches that target CRISPR sequences in skin bacteria, essentially reading the immune memory of the microbes themselves, have achieved about 95% accuracy in personal classification, compared with roughly 53% using conventional bacterial profiling.³⁸ Forensic microbiomics is nowhere near routine courtroom use, but the concept illustrates just how individualized these microbial communities are. Your microbiome is not just influencing your health; it is, in a very literal sense, part of what makes you you.

The Technology Behind Microbiome Science

A practical note on how these findings are generated. The two main approaches for studying microbial communities are targeted sequencing of a single bacterial gene and broader shotgun sequencing that reads all the DNA in a sample. A comparison of the two methods found that shotgun sequencing typically provides a more detailed and complete snapshot of microbial communities, while the targeted approach tends to emphasize dominant bacteria and miss rarer members. The choice of method matters: for stool samples and in-depth analyses, shotgun sequencing is generally recommended, while the simpler targeted approach may suffice for tissue samples or more focused questions.³⁹ This distinction is worth knowing because the methodology behind a study can shape how comprehensive its results are, and earlier microbiome research relying on less powerful tools may have missed important details that newer studies are now catching.